VersaVIT is a vitrectomy system for the retinal surgery market.
“The entry of VersaVIT into the global vitrectomy market is a major milestone in Synergetics’ strategy to enter into higher growth areas of retinal surgery,” said David Hable, president and CEO, in the release. “We believe that VersaVIT is a ‘game changer’ given its functionality, portability and competitive pricing relative to traditional vitrectomy systems.”
Synergetics USA is headquartered in O’Fallon, Mo.
Related Articles on FDA Clearances:
FDA Approves First Glaucoma Stent for Cataract Surgery
Cardinal Health Receives New FDA Clearance for Durablue Sterilization Wrap
InTouch Health Receives FDA 510(k) Clearance for Remote Presence Devices
